Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model

Journal of Gastrointestinal Surgery

Volumn 7, Issue 3, 2003, Pages 331-339

  Uhlmann, Dirk ^a   Armann, Barbara ^a   Gaebel, Gabor ^b   Ludwig, Stefan ^a   Hess, Jochen ^a   Pietsch, Uta Carolin ^a   Escher, Evelyn ^a   Fiedler, Martin ^a   Tannapfel, Andrea ^a   Hauss, Johann ^a   Witzigmann, Helmut ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Endothelin; Ischemia; Pig; Receptor antagonist; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BSF 208075; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; GLUTAMATE DEHYDROGENASE; OXYGEN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD; BLOOD FLOW; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG MECHANISM; ELECTRODE; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; LIVER ISCHEMIA; MICROCIRCULATION; NONHUMAN; OXYGEN TENSION; PHARMACOLOGICAL BLOCKING; POSTOPERATIVE PERIOD; RANDOMIZATION; RECEPTOR BLOCKING; REPERFUSION INJURY; SWINE; TISSUE SECTION; TREATMENT OUTCOME;

EID: 0038042303     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00417-1     Document Type: Article

References (25)

1. Bismuth H., Castaing D., Garden O.J. Major hepatic resection under total vascular exclusion. Ann Surg. 210:1989;13-19.
2. Uhlmann D., Witzigmann H., Senninger N.et al. Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury. Microvasc Res. 62:2001;43-54.
3. Masuko H., Jin M.B., Horiuchi H.et al. Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation. 71:2001;1034-1039.
4. Nakamura N., Hamada N., Murata R.et al. Contribution of serotonin to liver injury following canine small-intestinal ischemia and reperfusion. J Surg Res. 99:2001;17-24.
5. Scommotau S., Uhlmann D., Loffler B.M.et al. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg. 384:1999;65-70.
6. Nakamura S., Nishiyama R., Serizawa A.et al. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation. 59:1995;679-684.
7. Goto M., Takei Y., Kawano S.et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology. 19:1994;675-681.
8. Kawamura E., Yamanaka N., Okamoto E.et al. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology. 21:1995;1138-1143.
9. Okumura S., Takei Y., Kawano S.et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology. 19:1994;155-161.
10. Yanagisawa M., Kurihara H., Kimura S.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
11. Clozel M., Gray G.A., Breu V.et al. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 186:1992;867-873.
12. Davenport A.P. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev. 54:2002;219-226.
13. Zhang J.X., Pegoli W. Jr., Clemens M.G. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol. 266:1994;G624-G632.
14. Imakita M., Yamanaka N., Kuroda N.et al. Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in Beagle dogs. J Hepatol. 28:1998;204-211.
15. Uhlmann D., Uhlmann S., Spiegel H.U. Important role for endothelins in acute hepatic ischemia/reperfusion injury. J Invest Surg. 14:2001;31-45.
16. Koeppel T.A., Kraus T., Thies J.C.et al. Effects of mixed endothelin A and endothelin B-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia. Dig Dis Sci. 42:1997;1316-1321.
17. Lopez Farre A., Riesco A., Espinosa G.et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 88:1993;1166-1171.
18. Foitzik T., Faulhaber J., Hotz H.G.et al. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg. 228:1998;670-675.
19. Ota T., Hirai R., Urakami A.et al. Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion. Surg Today. 27:1997;313-320.
20. Battistini B., Forget M.A., Laight D. Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock. 5:1996;167-183.
21. Rockey D.C., Fouassier L., Chung J.J.et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat. potential for autocrine and paracrine effects on stellate cells Hepatology. 27:1998;472-480.
22. Ruetten H., Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages. ET-receptors, signal transduction and inhibition by dexamethasone J Physiol Pharmacol. 48:1997;675-688.
23. Post S., Rentsch M., Gonzalez A.P.et al. Importance of the first minutes of reperfusion in hepatic preservation injury. Transplant Proc. 27:1995;727-728.
24. Wilhelm S.M., Stowe N.T., Robinson A.V.et al. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation. 71:2001;211-216.
25. Katsuramaki T., Kimura H., Isobe U.et al. Changes in hepatic venous oxygen saturation in hepatic ischemia/reperfusion injury in pigs. Surg Today. 30:2000;343-351.